Spine News and Research

RSS

NEXUS criteria could reduce unnecessary CT scans and spare patients from radiation exposure

A Henry Ford Hospital study has found that better use of commonly accepted diagnostic guidelines for detecting cervical spine injuries could reduce unnecessary CT scans and spare patients from radiation exposure.

27 Nov 2012

High CT utilization could increase risk of breast cancer for certain women

Researchers reviewing the records of approximately 250,000 women enrolled in an integrated healthcare delivery system found that increased CT utilization between 2000 and 2010 could result in an increase in the risk of breast cancer for certain women, including younger patients and those who received repeat exams.

27 Nov 2012

Toshiba to showcase scalable Vantage Titan 1.5T MR series at RSNA 2012 meeting

Providing hospitals with MR technology that fulfills their financial needs and grows with their clinical needs, Toshiba America Medical Systems, Inc. will showcase the scalable Vantage Titan™ 1.5T MR series, which includes 8-, 16- and 32-channel MR systems, at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 25 - 30, 2012.

26 Nov 2012

Osteoporosis medication Aclasta now available on Canadian public drug plans

Osteoporosis Canada congratulates the Ontario government, the New Brunswick government, the Saskatchewan government and the British Columbia government for providing access to a new osteoporosis medication. Aclasta (zoledronic acid) is now available on public and private drug plans in Ontario, BC, SK, and NB meaning Canadians at high risk for fractures have access to increased treatment options.

23 Nov 2012

Even as leaders appear 'upbeat' after 'fiscal cliff' meeting, taxes, benefit programs remain flashpoints

President Barack Obama and House Speaker John Boehner, R-Ohio, appeared optimistic about a deal to avert automatic spending cuts and tax increases, but major issues must be tackled.

20 Nov 2012

Massimo CEO wins Ernst & Young Entrepreneur Of The Year Award

Joe Kiani, founder, CEO and Chairman of the Board of Massimo Corporation, has been named the Ernst & Young National Entrepreneur Of The Year 2012 Life Sciences Award Winner.

19 Nov 2012

Two genetic factors strongly associated with non-syndromic sagittal craniosynostosis

An international team of geneticists, pediatricians, surgeons and epidemiologists from 23 institutions across three continents has identified two areas of the human genome associated with the most common form of non-syndromic craniosynostosis ― premature closure of the bony plates of the skull.

18 Nov 2012

First HSS medical symposium to take place in Rio de Janeiro from Nov. 28-29

The first medical symposium in Brazil presented by Hospitalys Ortopedia in Rio de Janeiro and New York City's Hospital for Special Surgery (HSS) will take place November 28 and 29 in Rio de Janeiro.

16 Nov 2012

Study finds several osteoporosis risk factors among post-menopausal women on HRT

A preliminary study of 127 post-menopausal women on hormone replacement therapy in Portugal suggests that there are several risk factors associated with osteoporosis and bone fracture these include age, low bone mineral density, a sedentary lifestyle, coffee consumption and ovariectomy. Details are reported later this month in the International Journal of Medical Engineering and Informatics.

14 Nov 2012

Thrombin sponge speeds cervical spine surgery discharge

Application of a thrombin-soaked sponge after posterior cervical spine surgery allows patients to leave hospital earlier than normally expected, suggests research.

9 Nov 2012

University of Leicester scientists identify unique forms of spinal nerve activity

Scientists from the University of Leicester have hit upon unique forms of spinal nerve activity that shape output of nerve cell networks controlling motor behaviours.

9 Nov 2012

Two-level cervical disc from LDR receives approvable letter from U.S. FDA

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has received an Approvable Letter from the U.S. Food and Drug Administration (FDA) for its Mobi-C® Cervical Disc (Mobi-C). Mobi-C is a metal and polyethylene mobile bearing prosthesis specifically designed as a low-profile cervical intervertebral disc replacement for both one and two level applications.

7 Nov 2012

BioMimetic Therapeutics reports net loss of $4.6 million for third quarter 2012

BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.

6 Nov 2012

Nationwide standard on booster seat laws would save children’s lives

A new study by researchers in Boston Children's Hospital's Division of Emergency Medicine indicates that a nationwide standard on booster seat laws for children 4 feet 9 inches and shorter, or up to 8 years old, would save lives.

6 Nov 2012

New image guided instrumentation for DePuy Synthes Spine’s leading spine systems

DePuy Synthes Spine announced new image guided instrumentation for two of its leading spine systems and has entered into a new partnership agreement with Brainlab, enabling both companies to offer integrated surgical navigation and imaging solutions.

2 Nov 2012

FDA clears X-spine’s new Fortex and Certex system

X-spine, a global leader in the design and manufacture of devices for the treatment of spinal disease, today announced two new USFDA clearances for spinal systems: The Fortex CoCr Rod System and the Certex Cervico-thoracic Fixation System.

2 Nov 2012

Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.

1 Nov 2012

Encouraging results from stereotactic radiosurgery Phase I trial on kidney cancer

A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.

1 Nov 2012

Autoantibody aids identification of hyperexcitability disorders

Researchers have found that testing for a glycine receptor autoantibody aids the identification of a broad spectrum of autoimmune brainstem/spinal cord hyperexcitability disorders.

29 Oct 2012

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.

29 Oct 2012

Spine News and Research

NEXUS criteria could reduce unnecessary CT scans and spare patients from radiation exposure

High CT utilization could increase risk of breast cancer for certain women

Toshiba to showcase scalable Vantage Titan 1.5T MR series at RSNA 2012 meeting

Osteoporosis medication Aclasta now available on Canadian public drug plans

Even as leaders appear 'upbeat' after 'fiscal cliff' meeting, taxes, benefit programs remain flashpoints

Massimo CEO wins Ernst & Young Entrepreneur Of The Year Award

Two genetic factors strongly associated with non-syndromic sagittal craniosynostosis

First HSS medical symposium to take place in Rio de Janeiro from Nov. 28-29

Study finds several osteoporosis risk factors among post-menopausal women on HRT

Thrombin sponge speeds cervical spine surgery discharge

University of Leicester scientists identify unique forms of spinal nerve activity

Two-level cervical disc from LDR receives approvable letter from U.S. FDA

BioMimetic Therapeutics reports net loss of $4.6 million for third quarter 2012

Nationwide standard on booster seat laws would save children’s lives

New image guided instrumentation for DePuy Synthes Spine’s leading spine systems

FDA clears X-spine’s new Fortex and Certex system

Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

Encouraging results from stereotactic radiosurgery Phase I trial on kidney cancer

Autoantibody aids identification of hyperexcitability disorders

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News